H1N1 (Swine Influenza) Market Assessment

Questions: Discounts, Updates etc.

Pages: 60

Price (Single): $800

Price (Company): Kalorama

Publication Date: 2009-05-01

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *


The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in Swine Flu Market Alert 

Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The makers of certain tests will benefit both in terms of sales and more broadly in recognition that their products play a vital role in making the public health community significantly better prepared for this possible pandemic than 1968 or before.

The report examines:

The report focuses almost exclusively on the in vitro diagnostic industry as it applies to work being done by commercial entities and products that are either in development or have been brought to market.

The market assessment provided has been assembled based on publicly available information. Company sales data and other quantitative evaluations of the markets for flu diagnostics have been developed based on publicly available information and are expressed in US dollars, no adjustments have been made for currency exchange fluctuations.

Under normal circumstances, a report of this genre would be assembled from information derived from primary and secondary sources. However, in the short time it took to research and write this report, almost all of the major scientific and industry experts were occupied with the extraordinary task of preparing for a pandemic.

Therefore the information contained in this report has been assembled from a vast array of scientific and market publications, government sources, analyzed by a professional analyst.

Table of Contents


TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
  • Background
  • Exhibit 1: Flu Epidemics Compared to Present 1918-Today
  • Scope And Methodology
  • Point of View
  • Information SourcesCHAPTER TWO: 2009 SWINE INFLUENZA AND OTHER FLU EPIDEMICS
    • Influenza Overview
    • Overview of Virus Types
    • What’s So Special About This Latest Flu?
    • Flu Therapeutics
    • WHO Global Influenza Preparedness Plan
    CHAPTER THREE: FLU DIAGNOSTICS
    • Background
    • Exhbit 2: Influenza Test Innovations, 2009 (Company, Technology, Test Details, Status)
    • Immunoassays
      • Rapid Testing
      • Market Performance of Rapid Test
      • New Entrant Possiblity
      • Conclusion: Impact of Swine Flu on Rapid Testing
    • Molecular Assays
      • Molecular Influenza Detection Techniques
      • PCR, Sequencing or Both
      • Lessons and Market Impact of the H5N1 Epidemic
    CHAPTER FOUR: PROGNOSIS FOR A/H1N1
    • Background
    • Pandemic - Where? When?
      • 1976 Hsw1N1 Swine Flu Case
      • Comparing Past Flu Epidemics to 2009
      • International Reaction
    • Swine Flu and the IVD Industry
      • Origin of Flu Virus Mixes
      • PCR Test Development
      • Late-Breaking Research Developments
      • Use of Rapid Tests in Current Epidemic
    CHAPTER FIVE: COMPANIES AND PRODCUTS IMPACTED BY SWINE FLU EPIDEMIC
    • Immunoassays
      • 3M Medical Diagnostics
      • Becton, Dickinson and Company (BD)
      • Genzyme Corporation
      • Inverness Medical Innovations
      • Meridian Bioscience, Inc.
      • Quidel Corporation
      • Remel, Inc.
      • Response Biomedical Corporation
    • Molecular Tests
      • Arbor Vita Corporation
      • CombiMatrix Molecular Diagnostics (CMDX)
      • Diagnostic HYBRIDS, Inc. (DHI)
      • eGene Inc.
      • Eiken Chemical Co., Ltd
      • Life Technologies/Applied Biosystems/ Invitrogen Corporation (ABI)
      • Lab21
      • Laboratory Corporation of America Holdings (LabCorp)
      • Luminex Corporation
      • Nanogen
      • Prodesse Inc.
      • Qiagen N.V.
      • Seegene Inc.
      • Veredus Laboratories Pte
  • Other users found this report page using the following search terms: H1N1 Swine Influenza h1n1 swine influenza flu market prognosis kit report abi executive

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.